SEC filing · 8-K

Anavex Life Sciences Corp.: Change in control

Anavex stockholders elected all company director nominees in a contested vote, which triggered accelerated vesting of unvested equity awards.

Filed September 28, 2026

Mixed for the company

What happened

Stockholders elected all six company director nominees at the annual meeting and rejected all six nominees proposed by PVG Asset Management Corporation.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Anavex Life Sciences Corp.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.